Last $0.30 USD
Change Today +0.005 / 1.71%
Volume 731.0
CRXM On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert L. Engler M.D.

Chief Medical Advisor and Consultant, TaxuCardium Pharmaceuticals Group Inc.
AgeTotal Calculated CompensationThis person is connected to 48 board members in 4 different organizations across 5 different industries.

See Board Relationships
69--

Background*

Dr. Robert L. Engler, M.D. has been Chief Medical Advisor of Cardium Therapeutics Inc.., since November 29, 2005 and serves as its Consultant. Dr. Engler is a Cardiovascular Consultant of Angel Investor. He serves as a Scientific Advisor of Surgery & Heart Failure at PeriCor Therapeutics, Inc. He served as Vice President and Medical Director of Collateral Therapeutics from 1995 to 1998. He was Professor of Medicine at UCSD in Cardiology from 1975 to 2001, Associate Chief ...

Read Full Background

Corporate Headquarters*

11750 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-436-1000
Fax: 858-436-1001

Board Members Memberships*

Scientific Advisor of Surgery & Heart Failure and Director
Director
2004-Present
Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2005-Present
Director

Education*

MD
Georgetown University
BA
University of North Carolina

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRXM:US $0.30 USD +0.005

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAXUS CARDIUM PHARMACEUTICAL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.